Neoadjuvant exemestan alone or combined with metronomic chemotherapy (epirubicine; paclitaxel; docetaxel): efficacy plus tolerability. Final results of a multicenter phase I/II study (GENARI: German neoadjuvant arornasin initiative)

Wolf, C. and Blohmer, J. U. and Ortmann, O. and Krainick, U. and Eiermann, W. (2006) Neoadjuvant exemestan alone or combined with metronomic chemotherapy (epirubicine; paclitaxel; docetaxel): efficacy plus tolerability. Final results of a multicenter phase I/II study (GENARI: German neoadjuvant arornasin initiative). BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl1). S151. ISSN 0167-6806

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 11 Feb 2021 13:10
Last Modified: 11 Feb 2021 13:10
URI: https://pred.uni-regensburg.de/id/eprint/35088

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.